Abstract: This article analyzes the research problem of price-setting strategies for product innovations in the MedTech industry. It is based on the conceptual framework of price-setting practices, strategies, and models. A multiple case study research is then performed on six medical technology companies, focusing on how they set their initial product price for a new technology solution to either existing medical conditions or technology limitations. The research results show that MedTech companies opt for competition-informed price practices and buy pricing models. The pricing strategies vary between skimming and market-based pricing strategies. Price innovations are limited due to regulation and financial considerations.

Read more in the November 2017 issue of the ISM Journal of International Business (Pages 27-34).

More articles

Education in Crisis: The Impact of the Pandemic

by Maria Kuts, IEMBA, Partner Programs Manager

While discussions on how the pandemic has accelerated the Future of Work dominate, we in the education industry—academics,…

Read More

Resetting the Future: World 50.0

by Tamás Landesz, PhD Alumnus

I grew up in the seventies in the beautiful city of Buenos Aires, Argentina, where the skies are always blue. As a kid, I was…

Read More

A Disrupted Future

by César Baena, PhD, Dean and Director of Doctoral Research

One thing is certain: the post-COVID-19 world will not be back to business as usual. Entire economic sectors have been disrupted.…

Read More

Our Accreditation

Our Recognition

  • US State Authority to
    Confer Diplomas
  • Status with the French
    Ministry of Education
  • Établissement d'enseignement
    supérieur privé technique

Our Membership